U.S. markets close in 2 hours 34 minutes
  • S&P 500

    3,706.91
    +59.62 (+1.63%)
     
  • Dow 30

    29,613.71
    +478.72 (+1.64%)
     
  • Nasdaq

    10,991.08
    +161.58 (+1.49%)
     
  • Russell 2000

    1,708.93
    +46.42 (+2.79%)
     
  • Crude Oil

    81.74
    +3.24 (+4.13%)
     
  • Gold

    1,669.20
    +33.00 (+2.02%)
     
  • Silver

    18.88
    +0.54 (+2.93%)
     
  • EUR/USD

    0.9736
    +0.0138 (+1.44%)
     
  • 10-Yr Bond

    3.7470
    -0.2170 (-5.47%)
     
  • GBP/USD

    1.0891
    +0.0160 (+1.49%)
     
  • USD/JPY

    144.0200
    -0.7710 (-0.53%)
     
  • BTC-USD

    19,555.28
    +558.71 (+2.94%)
     
  • CMC Crypto 200

    445.64
    +16.86 (+3.93%)
     
  • FTSE 100

    7,005.39
    +20.80 (+0.30%)
     
  • Nikkei 225

    26,173.98
    -397.89 (-1.50%)
     

U.S. FDA panel recommends Ferring's fecal transplant therapy

Sept 22 (Reuters) - A panel of U.S. Food and Drug Administration advisers voted in favor of Ferring Pharmaceuticals' fecal transplant-based therapy to reduce recurrent infections caused by a bacteria known as C. difficile.

The therapy is based on the concept of replenishing the good gut bacteria through samples of microbes distilled from faeces of healthy donors, delivered through an enema in this case. (Reporting by Manas Mishra and Raghav Mahobe in Bengaluru; Editing by Shinjini Ganguli)